Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Doug Loe has done it again

<< Previous

Bullboard Posts

Next >>

Comment by donkeyfeatherson Jan 07, 2022 12:51pm

236 Views

Post# 34293572

RE:Doug Loe has done it again

SF,
Perfect summary! The fix is in. This "call" has everything to do with a "target" that is nothing more than self-serving drivel. There is genuine fear that both houses in the bought deal will actually have to pony up because there is a very real - retail market lead - push to align share valuation with the public's expectations (diabetes cured??). Anyone who is still thinking that LJ and Can-o-worms are in this for the good of the company (and those who've kept the company alive this long) need to give their heads a shake!
DF

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing